0001485003-17-000029.txt : 20170405 0001485003-17-000029.hdr.sgml : 20170405 20170405161618 ACCESSION NUMBER: 0001485003-17-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170403 FILED AS OF DATE: 20170405 DATE AS OF CHANGE: 20170405 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeCillis Arthur CENTRAL INDEX KEY: 0001685148 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 17742758 MAIL ADDRESS: STREET 1: C/O ELEVEN BIOTHERAPEUTICS STREET 2: 215 1ST ST. #400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 wf-form4_149142336243033.xml FORM 4 X0306 4 2017-04-03 0 0001485003 Eleven Biotherapeutics, Inc. EBIO 0001685148 DeCillis Arthur C/O ELEVEN BIOTHERAPEUTICS, INC. 245 FIRST STREET, SUITE 1800 CAMBRIDGE MA 02142 0 1 0 0 Chief Medical Officer Employee Stock Option (Right to Buy) 2.28 2017-04-03 4 A 0 19246 0 A 2027-04-02 Common Stock 19246.0 19246 D 50% of the shares subject to such option shall vest on grant date with the remaining 50% of shares underlying the option to vest on the first anniversary of the grant date. /s/ Arthur P. DeCillis, M.D. 2017-04-05